chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Some swelling and pain in armpit after vaccination; Some swelling and pain in armpit after vaccination; dose number: 3; This is a spontaneous report from a contactable reporter (consumer or other non-HCP).   A 31-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in left arm, administration date 02Dec2021 (Lot number: FH8030) at the age of 31 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Cancer" (unspecified if ongoing), notes: Cancer, currently healthy. Concomitant medications included: ADDERALL and IBUPROFEN. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EP7534), administration date: 31Mar2021, when the patient was 30 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot number: EP7534), administration date: 21Apr2021, when the patient was 30 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021, outcome "unknown", described as "dose number: 3"; SWELLING (non-serious) and AXILLARY PAIN (non-serious) both with onset 03Dec2021, outcome "recovering", both described as "Some swelling and pain in armpit after vaccination". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of swelling and axillary pain.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.
Patch of bright red stinging, itchy rash like a bug bite two inches round---"Covid arm"
Blood pressure fluctuation with the current reading of 89/49 mmHg; Pulse rate and heart rate that is fluctuating to around 106-162 bpm and is currently at 180 bpm now; fever of 102F-103F; chills; SpO2 also keeps fluctuating every 5-10 second with a current reading of 94 , his normal ranges are within 98-99; This is a spontaneous report from a contactable consumer reported for father via medical information team. A 69-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 27May2021 as 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant drugs not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unknown date as 1st dose, single dose for COVID-19 immunization. On an unspecified time later in May2021, as of the moment, the patient was having fever of 102F-103F and chills. Pulse rate and heart rate that was fluctuating to around 106-162 bpm and was currently at 180 bpm now. He also was experiencing some blood pressure fluctuation with the current reading of 89/49 mmHg, SpO2 also kept fluctuating every 5-10 second with a current reading of 94, his normal ranges were within 98-99. The reporter wanted to know if these were commonly reported side effect after getting the vaccine. The outcome of all the events was unknown.  Information on the lot/batch number has been requested.
Hand on arm that shot was administered has a tingling feeling that has been going on since a couple hours after shot. Feels like when your hand is "waking up" after "falling asleep" doesn't hurt, it just won't stop doing it
Information has been received from a nurse referring to multiple unspecified patients of unknown ages and genders. The patients' medical history and concurrent conditions were not reported.  Concomitant therapies included sterile diluent (MERCK) that was properly stored. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot number M049126 with expiration date on 15-DEC-2018 or with other lot number reported as "N012201 with expiration date on 09-JUN-2019" (anatomical location, dose, and administration route were not reported); the unspecified patients could be also vaccinated with improperly stored doses of PROQUAD lot number N019826 with expiration date on 09-JAN-2019; Lot number N015622 with expiration date on 15-NOV-2018 or lot number N015621 with expiration date on 15-NOV-2018 (anatomical location, dose, and administration route were not reported) or with improperly stored doses of ZOSTAVAX lot number N020945 with expiration date on 26-OCT-2018 (anatomical location, dose, and administration route were not reported) all the vaccines used for prophylaxis. No adverse effects were reported. The vaccines had a temperature excursion of 6 Fahrenheit (F) to 14 F, during a time frame of 1 hour and 12 minutes. It was confirmed that no previous temperature excursions occurred and a digital data logger was involved. Lot number N012201 is an invalid lot number for varicella virus vaccine live (oka/merck)."
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 24-JAN-2017  at 11:02, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) ( expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704.
Pt was given 4 different injections & after about 5 min when pt was getting off table, she sat down in a chair and fainted, was out for 45 sec & was in & out of consciousness x at least - 20-30 min - was transported to hospital.
pt exp joint pain (especially hands & rt knee); generalized malaise w/fatigue; enlarge liver (according to personal MD); erythematous area initially 3cm -10cm; swollen; hot site; symptoms worsened p/each shot;continues to have joint pain
Swelling of cheeks, tongue and chin; Swelling of cheeks, tongue and chin; Redness or arms and face; chills; shortness of breath; This is a spontaneous report from a contactable consumer reporting for himself. A 58-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration, administered in Arm Right (At vaccination age 58-year-old) on 12Mar2021 08:00 (Batch/Lot number was not reported) as single dose for covid-19 immunization. Medical history included Heart disease, known allergies: Sulfa meds from an unknown date. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient took other medication in last two weeks. The patient experienced swelling of cheeks, tongue and chin, redness or arms and face, chills, and shortness of breath 12Mar2021 08:15 AM. Therapeutic measures were taken as a result of events which include BENEDRYL and rest. The outcome for all events were recovering.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Pt administered 1st dose of vax; @ that time, pt was inadvertently administered 3ml dose of Hep vax instead of 1ml; No futher details were provided;
While we were talking, within 5 minutes of FLUZONE given IM, Patient noticed to become lethargic, diaphoresis, pale looking, warm to touch, and very drowsy. She noticed to have a one second long of generalized jerky movement of upper/lower extremities while sitting in the chair. Vital signs as followed: 107/69 (right upper arm), 97% on room air, 72bpm HR. Radial pulses: 2+ palpable bilateral. Reposition Patient to the floor/flat position, cold towel applied to forehead/neck areas, verbal stimulation provided by myself and her mother. Patient opened eyes and verbalized feeling hot/dizziness, no further jerky movement noticed but she remained lethargic. No rash/no SOB noticed. Rapid Response and 911 called, teams arrived within 5 minutes. By then Patient already recovered, alert, awake, responsive, no resp. distress. Vital signs: 109/79, HR 66, 97% on room air. Since Patient is now better, no S/S of allergic reaction, can stand up, and ambulate. No residual of what happened, able to communicate well with paramedic, mother and staff, and drink water. Mother declined ER visit. Total time of event: approximate 30min.
patient reported developing a severe cough that brought up excessive mucus and brought her to the point of throwing up
Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Patient called 2 1/2 hours after shot stating she has what look like broken blood vessels all over her body.
Delayed injection site reaction 8 days after dose. Area became red, warm to touch, inflamed and itchy. Resolved on its own in 3 days or so.
Development of Guillain-barre syndrome 2 weeks after vaccine administration, with weakness, lethargy, pain, mild respiratory symptoms...admitted to hospital, treated with IVIG 8/1/07-records received for DOS 7/13-7/17/07- DC DX: Guillain-Barre syndrome versus mononeuritis multiplex. Atrial fibrillation. Presented to ED with C/O left hand pain in dorsum of hand worsened with attempting pincher grip. Denies  numbness. C/O progressive weakness in upper and lower extremities. RX with IVIG.
Medical Assistant Apprentice administered incorrect vaccine. Order was for HEP A administered HEP A+B.  Patient contacted, has not experienced any side effects at this time.
Information has been received from a registered nurse concerning a 33 year old female who was vaccinated with her first dose of GARDASIL (lot number not reported) 0.5ml IM into her left deltoid.  There was no concomitant medication.  Two days after administration, "a few week ago" the patient experienced soreness at the injection site.  The patient then developed induration at the injection site.  The patient was examined in the office but no treatment was prescribed.  The current status of the patient was unknown. Follow-up information was received from the registered nurse concerning the patient with penicillin allergy (rash) who on 20-JAN-2009 was vaccinated with her first dose of GARDISIL (lot number 661766/0052X). On 20-JAN-2009 the patient had a hard, sore and circular area around injection site that developed a couple days after injection. The outcome was un known. There was no illness at the time of the vaccination.  Additional information has been requested.
Pt experienced a fever of 103 to 104 a few hours post vax that lasted for 2 days, with marked irritability.
Extreme pain x 8 hours right arm with movement limitations x 3 weeks, headache, fatigue, sore throat, muscle aches, chills, fever x 30 hours.  Headache continuing another 6 hours.  Swollen lymph nodes lower back still enlarged almost 4 weeks later - now achy along with bilat thighs.  Ongoing fatigue.  Aggravation of migraines x 3 (could be unrelated).  Did have strep throat diagnosis 3 days after injection resolving quickly with PCN antibiotics.
Covid; Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Mar2022, outcome "unknown" and all described as "Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (10Mar2022) positive, notes: tested positive for Covid 19. Therapeutic measures were taken as a result of drug ineffective, covid-19.Clinical information: The patient was treated with 100 mg of ritonavir and 2 tablets of nirmatrelvir 150mg each. No Other Products. No Patient History.  The lot number for bnt162b2 was not provided and will be requested during follow up.
While I had already had a rash that day around my eyes and across my trunk (itchy with raised bumps that I had excoriated from scratching), the rash that appeared the morning following the vaccine was a different kind of rash-a red flush across my trunk.
Migraine, facial numbness and tingling central to nose and mouth area. Feeling like she was unable to breathe when ascending steps that resulted in hyperventilating which lasted 18 minutes. Normal breathing rhythm returned after 43 minutes.  Right arm extremely tender. Oxygen and heart rate at 23 min were 98  for O2 and heart rate 73 BPM.
Swelling slightly larger than a 50 cent piece; Big welt at the injection site; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Big welt at the injection site), VACCINATION SITE PAIN (Arm was sore) and VACCINATION SITE SWELLING (Swelling slightly larger than a 50 cent piece) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history were reported.).    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 08-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Big welt at the injection site). On 11-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling slightly larger than a 50 cent piece). At the time of the report, VACCINATION SITE URTICARIA (Big welt at the injection site), VACCINATION SITE PAIN (Arm was sore) and VACCINATION SITE SWELLING (Swelling slightly larger than a 50 cent piece) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided.  Company comment:Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Shoulder inflammation; shoulder pain and still persists with a lot pain on sleeping; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER 8729) via an unspecified route on 05Apr2021 at 16:00 in the left arm (at an age of 47-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:00, the patient experienced shoulder inflammation and pain where vaccination was administered in the left shoulder which persisted with a lot of pain on sleeping. Therapeutic measures were taken as a result of the events and included treatment with medications (unspecified). The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of shoulder inflammation and pain where vaccination was administered in the left shoulder which persisted with a lot of pain on sleeping were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Day 1 the medicine burned going in , arm hurt really bad , day 2 swelling and redness, and itching, headache, fatigue, pain in my neck, nausea
Temperature increase day after vaccine from usual temp of 96.0 to 99.0 which decreased without medication after about 4 hours. Developed facial rash 2 days after vaccine that still remains on face. No issues breathing and no rash noted anywhere else on body.
I sat down in the observation area and went home. I was fine until the 2nd day. I was sore, couldn't move, super heavy chest and felt like my body was shutting down. Went to ER and was told that it was possibly the vaccine since I had COVID in August. I went home, got rest and took Tylenol as directed. After 2 or 3  days, I felt better.
Patient had redness and swelling at injection site. Advised patient to contact her doctor to determine if further medical treatment was needed.
This spontaneous report as received from a Licensed Nurse refers to a patient of 11 years old child patient and unknown gender. On 23-JUL-2014 the patient was vaccinated with a dose of an improperly stored GARDASIL (lot H020901, expiration date 05-JUL-2015) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
Around 10 pm started to develop chills, fever was 100.8. Severe body ache and headache .  Fever was going on and off during the night . In the morning when get up to take a Tylenol and use the bathroom I felt very dizzy , later done not remember because I lost of continuous. After recovered I found myself on the bed, sweating and feeling nauseous, vomited. The rest of the day still headache , weakness.
The caller said the patient received a dose of MMRII on 7/5/2023, aft; No additional adverse event; This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. The patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX). Additionally, the patient's pertinent medical history, drug reactions or allergies were not provided.  On 27-JUN-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, one dose, lot number was reported as W039699, which upon internal review was determined to be a valid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), expiration date was reported and determined to be valid as 25-MAY-2024, albumin status rHA, administered as prophylaxis (strength, dose, frequency, route of administration, albumin status, and anatomical location was not provided) after a temperature excursion (product storage error) with a temperature of 48.8 degree Fahrenheits for 7 hours and 45 minutes. No adverse event reported.  This is one of the several reports from the same reporter.; Sender's Comments:  US-009507513-2307USA006147:
5hr p/vax pt c/o chills & flu-like feeling, achy, no fever;blood noted on toilet tissue post void;encouraged fluids & suggested APAP;instructed to contact MD for worsening of sx;lasted 4hr;
Big red spot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Big red spot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Big red spot). At the time of the report, ERYTHEMA (Big red spot) outcome was unknown.            No relevant concomitant medications were reported.   Treatment information was not provided.  Patient has got a big red spot after second dose of vaccination.
High fever (104.5) for 1 hour (approx) with no other symptoms, then 2 episodes of vomiting the next day. No other fever or other symptoms continued.